Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 112,744 shares at $102.88 ($11.6M) on 2025-06-04, disclosed to the SEC on 2025-06-04.
Scheduled sale ($11.6M) by EVP & Group President, Cardiology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $102.88 | 56,372 | $5.8M | 50.0% |
| 2 | $102.88 | 56,372 | $5.8M | 50.0% |
| Total | $102.88 avg | 112,744 | $11.6M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |